White & Case LLP has advised Novasep on the issuance of €181 million principal amount of  OBSAs (bonds with share warrants attached) maturing in May 2019 in exchange for US$195 million principal amount of  Novasep's existing high yield bonds due on December 15, 2016 pursuant to an exchange offer and consent solicitation.

Novasep is a leading global provider of integrated purification and manufacturing solutions to pharmaceutical and other life science industries.

The White & Case team in Paris that advised on the transaction was led by partner François Leloup with support from associate Camille Note. Partners Colin Chang and Philippe Herbelin, with support from Counsel Elsa Imbernon and associate Mathieu Damnon, advised on the capital market aspects. Associates James Greene, Michael Lee and Diogo Metz (all London) also assisted in the transaction.